Glyphic Biotechnologies

company

About

Next generation protein sequencing.

  • 11 - 50

Details

Last Funding Type
Grant
Last Funding Money Raised
$409.29K
Industries
Biotechnology,Life Science
Founded date
Jan 1, 2021
Number Of Employee
11 - 50
Operating Status
Active

We sequence proteins. Glyphic Biotechnologies is a biotechnology startup revolutionizing the field of proteomics. While DNA can reveal biological insights, proteins actually tell us what our bodies will do. We are developing a first-of-its-kind, next-generation protein sequencing platform to enable researchers to gain novel insights into biology and disease.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$409.29K
Glyphic Biotechnologies has raised a total of $409.29K in funding over 2 rounds. Their latest funding was raised on Sep 2, 2022 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Sep 2, 2022 Grant $409.29K 1 National Institutes of Health Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Glyphic Biotechnologies is funded by 1 investors. National Institutes of Health are the most recent investors.
Investor Name Lead Investor Funding Round
National Institutes of Health Yes Grant